Products
| Product Name | CAS No. | Specification | Application | Registration |
| Docetaxel Trihydrate | 148408-66-6 | 99+% | ||
| Docetaxel | 114977-28-5 | 98+% | ||
| Deferasirox | 201530-41-8 | 99+% | ||
| Dabigatran Etexilate Mesylate | 872728-81-9 | 99+% | ||
| Dapoxetine Hydrochloride | 129938-20-1 | 98+% | ||
| Dirithromycin | 62013-04-1 | 98+% | ||
| Decitabine | 2353-33-5 | 99+% | ||
| Dihydroartemisinin (DHA) | 71939-50-9 | 98+% | ||
| Doxercalciferol | 54573-75-0 | 99+% | A VD2 analog, activates VDR, prevents renal disease. | |
| Dacarbazine | 4342-03-4 | 99+% | ||
| Dapagliflozin Propanediol Monohydrate | 960404-48-2 | 98+% | ||
| Dinoprost Tromethamine Salt | 38562-01-5 | 98+% | Prostaglandin Receptor agonist | |
| Dipeptide Diaminobutyroyl Benzylamide Diacetate | 823202-99-9 | 98+% | mAChR antagonist. | |
| Docosahexaenoic Acid (DHA) | 6217-54-5 | 98+% | ||
| Daunorubicin Hydrochloride | 23541-50-6 | 99+% | Antineoplastic Agents | Antineoplastic and Immunosuppressive Antibiotics inhibitor | Topoisomerase inhibitor | ADC Cytotoxin | COVID-19 inhibitor | DNA/RNA Synthesis inhibitor | Apoptosis related activator |
Products
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn